Bora Pharmaceuticals has entered into an agreement to acquire Emergent BioSolutions’ sterile manufacturing facility in Baltimore-Camden, Maryland as part of a major commercial expansion for the company. Bora has an established footprint in the U.S. following its acquisition of Upsher-Smith Laboratories, a generics manufacturer based in Minnesota, earlier this year. This second acquisition is the next milestone in the company’s growth strategy, as it continues its plans to expand into sterile ...